Feuerstein On Neurotrope: The Study Failed And There Was Never 'A Lot Of Hope Here'

By: via Benzinga
Neurotrope Inc (NASDAQ: NTRP) announced “positive topline results” for its leading Alzheimer's drug in a press release, ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.